Unknown

Dataset Information

0

Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders.


ABSTRACT: Lysosomal storage disorders characterized by altered metabolism of heparan sulfate, including Mucopolysaccharidosis (MPS) III and MPS-II, exhibit lysosomal dysfunctions leading to neurodegeneration and dementia in children. In lysosomal storage disorders, dementia is preceded by severe and therapy-resistant autistic-like symptoms of unknown cause. Using mouse and cellular models of MPS-IIIA, we discovered that autistic-like behaviours are due to increased proliferation of mesencephalic dopamine neurons originating during embryogenesis, which is not due to lysosomal dysfunction, but to altered HS function. Hyperdopaminergia and autistic-like behaviours are corrected by the dopamine D1-like receptor antagonist SCH-23390, providing a potential alternative strategy to the D2-like antagonist haloperidol that has only minimal therapeutic effects in MPS-IIIA. These findings identify embryonic dopaminergic neurodevelopmental defects due to altered function of HS leading to autistic-like behaviours in MPS-II and MPS-IIIA and support evidence showing that altered HS-related gene function is causative of autism.

SUBMITTER: De Risi M 

PROVIDER: S-EPMC8190083 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3988112 | biostudies-literature
| S-EPMC2768319 | biostudies-literature
| S-EPMC9026333 | biostudies-literature
| S-EPMC3435187 | biostudies-literature
| S-EPMC2893380 | biostudies-literature
| S-EPMC4588229 | biostudies-other
| S-EPMC3500170 | biostudies-literature
| S-EPMC3565645 | biostudies-literature
| S-EPMC2423263 | biostudies-literature
| S-BSST1274 | biostudies-other